Who's to blame for tragic error?

Grant discusses the controversy at the Dana-Farber Cancer Institute that has affected nurses there. The controversy revolves around the death of a patient who had received four times the intended amount of high-dose chemotherapy. Dana-Farber hasn't blamed individuals, but has worked to improve...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of nursing 1999-09, Vol.99 (9), p.9
Main Author: Grant, S M
Format: Article
Language:English
Subjects:
Antineoplastic Agents - therapeutic use
Breast Neoplasms - drug therapy
Breast Neoplasms - nursing
Chemotherapy
Clinical Trials, Phase I as Topic - standards
Drug Overdose
Fatal Outcome
Fatalities
Female
Humans
Massachusetts
Medication Errors
Negligence
Nurses
Oncology Nursing - standards
Social Responsibility
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Grant discusses the controversy at the Dana-Farber Cancer Institute that has affected nurses there. The controversy revolves around the death of a patient who had received four times the intended amount of high-dose chemotherapy. Dana-Farber hasn't blamed individuals, but has worked to improve overall patient care.
ISSN:0002-936X
1538-7488
DOI:10.1097/00000446-199909000-00002